CERS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.95

Margin Of Safety %

Put/Call OI Ratio

0.14

EPS Next Q Diff

EPS Last/This Y

0.05

EPS This/Next Y

0.03

Price

2.7

Target Price

4.67

Analyst Recom

Performance Q

13.87

Upside

-164.6%

Beta

1.68

Ticker: CERS

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-24	CERS	1.98	0.10	0.01	5102
2026-04-27	CERS	1.99	0.10	0.00	5053
2026-04-28	CERS	1.975	0.10	0.00	5055
2026-04-29	CERS	1.92	0.10	0.00	5060
2026-04-30	CERS	2.02	0.10	0.03	5069
2026-05-01	CERS	2.72	0.10	0.03	5103
2026-05-04	CERS	2.71	0.08	0.01	7292
2026-05-05	CERS	2.58	0.09	0.35	6669
2026-05-06	CERS	2.59	0.09	0.14	6686
2026-05-07	CERS	2.62	0.09	0.08	6760
2026-05-08	CERS	2.62	0.09	0.14	6882
2026-05-11	CERS	2.52	0.09	0.59	6885
2026-05-12	CERS	2.56	0.09	0.18	6850
2026-05-13	CERS	2.59	0.11	0.08	6984
2026-05-14	CERS	2.52	0.11	0.30	6944
2026-05-15	CERS	2.34	0.10	0.35	6939
2026-05-18	CERS	2.43	0.15	0.09	4555
2026-05-19	CERS	2.69	0.15	0.02	4601
2026-05-20	CERS	2.69	0.14	0.01	4867
2026-05-21	CERS	2.74	0.14	0.02	4907
2026-05-22	CERS	2.7	0.14	0.05	5016
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-24	CERS	1.98	12.5	-	-0.06
2026-04-27	CERS	1.99	12.5	-	-0.06
2026-04-28	CERS	1.98	12.5	-	-0.06
2026-04-30	CERS	2.02	12.5	-	-0.06
2026-05-01	CERS	2.72	12.5	-	-0.06
2026-05-04	CERS	2.72	12.5	-	-0.06
2026-05-05	CERS	2.59	12.5	-	-0.04
2026-05-06	CERS	2.59	12.5	-	-0.04
2026-05-07	CERS	2.62	12.5	-	-0.03
2026-05-08	CERS	2.62	12.5	-	-0.03
2026-05-11	CERS	2.53	66.7	-	-0.03
2026-05-12	CERS	2.56	66.7	-	-0.03
2026-05-13	CERS	2.60	66.7	-	-0.03
2026-05-14	CERS	2.51	66.7	-	-0.03
2026-05-15	CERS	2.35	66.7	-	-0.03
2026-05-18	CERS	2.43	66.7	-	-0.03
2026-05-19	CERS	2.70	66.7	-	-0.03
2026-05-20	CERS	2.69	66.7	-	-0.03
2026-05-21	CERS	2.74	66.7	-	-0.03
2026-05-22	CERS	2.70	66.7	-	-0.03
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-24	CERS	-11.17	1.64	6.13
2026-04-27	CERS	-11.17	1.21	6.18
2026-04-28	CERS	-11.17	1.21	6.18
2026-04-29	CERS	-11.17	1.21	6.18
2026-04-30	CERS	-10.76	1.21	5.93
2026-05-01	CERS	-10.76	1.21	5.93
2026-05-04	CERS	-10.76	4.60	5.93
2026-05-05	CERS	-10.76	4.60	5.93
2026-05-06	CERS	-10.88	4.60	5.93
2026-05-07	CERS	-10.88	4.60	5.93
2026-05-08	CERS	-10.88	4.60	5.93
2026-05-11	CERS	-10.88	4.59	5.93
2026-05-12	CERS	-10.89	4.59	5.96
2026-05-13	CERS	-10.89	4.59	5.96
2026-05-14	CERS	-10.89	4.59	5.96
2026-05-15	CERS	-10.89	4.59	5.96
2026-05-18	CERS	-10.89	5.39	5.95
2026-05-19	CERS	-11.30	5.39	5.95
2026-05-20	CERS	-11.30	5.39	5.95
2026-05-21	CERS	-11.30	5.39	5.95
2026-05-22	CERS	-11.30	5.39	5.95
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.01

Avg. EPS Est. Current Quarter

-0.01

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

-11.3

Institutional Transactions

5.39

Beta

1.68

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

66.4

Max Drawdown 5-Year %

-85.4

Target Price

4.67

P/E

Forward P/E

PEG

P/S

2.51

P/B

8.04

P/Free Cash Flow

EPS

-0.05

Average EPS Est. Cur. Y

-0.03

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-4.41

Relative Volume

0.71

Return on Equity vs Sector %

-41.2

Return on Equity vs Industry %

-26

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ CERS Healthcare

$2.71

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

6/20

Pullback

10/25

Volume

9/15

Valuation

11/20

TP/AR

2/10

Options

8/10

RSI

64.4

Range 1M

67.7%

Sup Dist

1.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

28/30

Estimates

2/20

Inst/Vol

8/15

Options

8/10

EPS Yr

58.3%

EPS NY

90%

52W%

79%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +72.3% upside

Quality

5/30

Valuation

15/30

Growth

20/25

Stability

5/10

LT Trend

4/5

Upside

+72.3%

Quality

Cerus Corporation

Sector: Healthcare

Industry: Medical Devices

Employees: 261

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.

CERS

Latest News

—

Caricamento notizie per CERS…

stock quote shares CERS – Cerus Corporation Stock Price stock today

news today CERS – Cerus Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch CERS – Cerus Corporation yahoo finance google finance

stock history CERS – Cerus Corporation invest stock market

stock prices CERS premarket after hours

ticker CERS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CERS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y